Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 1 1

Status

Recruiting 2Not yet recruiting 2Active not recruiting 2Completed 1

Sponsor Class

OTHER 7INDUSTRY 6

Study Type

Interventional 7

Sponsor

Cancer Type

Gastrointestinal 7

Conditions

Rectal Neoplasms 2Esophageal Neoplasms 1Colorectal Neoplasms 1Cholangiocarcinoma 1Carcinoma, Hepatocellular 1Biliary Tract Neoplasms 1Advanced Rectal Cancer 1Adenocarcinoma Of Esophagus 1

Interventions

Specimen Handling 74Magnetic Resonance Spectroscopy 73Cyclophosphamide 69pembrolizumab 57Nivolumab 49Radiotherapy 48fludarabine 41Cisplatin 39Standard of Care 34Carboplatin 33Biopsy 33Bevacizumab 29Dexamethasone 28Rituximab 25Radiation 25Temozolomide 24Surveys and Questionnaires 24Radiosurgery 24Practice Guidelines as Topic 24Gemcitabine 24Doxorubicin 24Blood Specimen Collection 24venetoclax 23Cytarabine 23fludarabine phosphate 22Paclitaxel 21atezolizumab 20Ipilimumab 20Interviews as Topic 19Fluorouracil 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
OTHER × Folfox protocol × 30 days × Clear all
NCT03781323 2026-06-04

Neoadjuvant FOLFOX Therapy With Short Course Radiation and Active Surveillance in Locally Advanced Rectal Cancer

University of Rochester

Phase 2 Active not recruiting
12 enrolled 9 charts
Gastrointestinal

Advanced Rectal Cancer

NCT07622017 2026-06-02

K-BOOST

Gustave Roussy, Cancer Campus, Grand Paris

Phase 2 Not yet recruiting
24 enrolled
Gastrointestinal

Rectal Neoplasms

NCT07500298 2026-06-01

Phase 1 Study Of SAR445877 In Combination With FOLFOX6 And Bevacizumab As First-Line Treatment For Microsatellite Stable Metastatic Colorectal Cancer

M.D. Anderson Cancer Center

Phase 1 Recruiting
41 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT07603375 2026-05-29

TNT Esophagus

Duke University

Phase 2 Not yet recruiting
60 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

NCT03548961 2026-05-22

Organ Preservation in Early Rectal Cancer Patients

Fox Chase Cancer Center

Phase 2 Active not recruiting
19 enrolled
Gastrointestinal

Rectal Neoplasms

NCT05099848 2026-05-22

A Trial of Conversion Treatment of HAIC Combined With Camrelizumab and Apatinib for Unresected Hepatocellular Carcinoma

Shandong Cancer Hospital and Institute

Phase 2 Completed
21 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT06529718 2026-05-19

SEVILLA

UNICANCER

Phase 2 Recruiting
72 enrolled
Gastrointestinal

Biliary Tract Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡